Invention Grant
US09328159B2 Multimeric IL-15 soluble fusion molecules and methods of using same
有权
多聚IL-15可溶性融合分子及其使用方法
- Patent Title: Multimeric IL-15 soluble fusion molecules and methods of using same
- Patent Title (中): 多聚IL-15可溶性融合分子及其使用方法
-
Application No.: US13854903Application Date: 2013-04-01
-
Publication No.: US09328159B2Publication Date: 2016-05-03
- Inventor: Hing C. Wong , Peter Rhode , Bai Liu , Xiaoyun Zhu , Kai-ping Han
- Applicant: Altor BioScience Corporation
- Applicant Address: US FL Miramar
- Assignee: Altor Bioscience Corporation
- Current Assignee: Altor Bioscience Corporation
- Current Assignee Address: US FL Miramar
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Peter F. Corless, Esq.; Daniel W. Clarke
- Main IPC: C07K14/715
- IPC: C07K14/715 ; C07K14/54 ; C07K16/18 ; A61K38/20 ; A61K38/00
Abstract:
The present invention features compositions and methods featuring ALT-803, a complex of an interleukin-15 (IL-15) superagonist mutant and a dimeric IL-15 receptor α/Fc fusion protein useful for enhancing an immune response against a neoplasia (e.g., multiple myeloma, melanoma, lymphoma) or a viral infection (e.g., human immunodeficiency virus).
Public/Granted literature
- US20140134128A1 MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME Public/Granted day:2014-05-15
Information query
